CIK 0001053691 · Non-accelerated filer<br>Smaller reporting company
CervoMed Inc.
Sign in to watch- Ticker
- CRVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 300645032
- Phone
- (617) 744-4400
- Business address
- 20 PARK PLAZA, SUITE 424, BOSTON, MA, 02116
- Former names
- Diffusion Pharmaceuticals Inc., RestorGenex Corp, Stratus Media Group, Inc, FERIS INTERNATIONAL, INC., TITAN MOTORCYCLE CO OF AMERICA INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market buy Chief Commercial and Business bought 5,000 shares at an average $8.29 ($41,430)
- 4 Open-market buy Director bought 21,600 shares at $8.46 ($182,736)
- 4 Open-market buy CFO, GC & Secretary bought 3,500 shares at an average $8.36 ($29,250)
- 4 Open-market buy CEO & President bought 21,600 shares at $8.46 ($182,736)
- 4 Open-market buy Director bought 7,847 shares at an average $7.53 ($59,101)
- 4 Open-market buy CEO & President bought 7,847 shares at an average $7.53 ($59,101)
- 4 Open-market buy Chief Commercial and Business bought 10,000 shares at $7.57 ($75,700)
- 4 Open-market buy Director bought 5,553 shares at $7.35 ($40,815)
- 4 Open-market buy CFO, GC & Secretary bought 3,500 shares at $7.44 ($26,040)
- 4 Open-market buy CEO & President bought 5,553 shares at $7.35 ($40,815)
- 8-K Event Results of operations
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 4 of 51 · 1,005 filings